| tDCS and Speech Therapy for Motor Speech Disorders Caused by FTLD Syndromes: a Feasibility Study (NCT04883229) | University of California, San Francisco | 2022-07-01 |
| Community Outreach for Palliative Engagement -- Parkinson Disease (NCT05222386) | University of Rochester | 2022-04-26 |
| Neurological Soft Signs in Neurodegenerative Dementias (NCT06354933) | University of Milano Bicocca | 2022-04-01 |
| Sociodemographic Factors and Criminal Behaviour Preceding Neurodegenerative Disease - Retrospective Register Study (NCT06209515) | Kuopio University Hospital | 2022-01-01 |
| Optimization of Morphomer-based Alpha-synuclein PET Tracers (NCT05067192) | Skane University Hospital | 2021-07-15 |
| Complex Eye Movements in Parkinson's Disease and Related Movement Disorders (NCT04925622) | Saccadous, Inc. | 2021-01-04 |
| Autologous Stem/Stromal Cells in Neurological Disorders and Disease (NCT03297177) | Regeneris Medical | 2020-01-01 |
| Misfolded Proteins in the Skin of People With Parkinson's Disease and Other Parkinsonism (NCT04518059) | University Hospitals Cleveland Medical Center | 2019-03-12 |
| Brain Network Activation in Patients With Movement Disorders (NCT03269201) | Sheba Medical Center | 2019-03-01 |
| Subcutaneous Apomorphine in the Treatment of Progressive Supranuclear Palsy and Cortico Basal Degeneration (APOPARKA) (NCT04786158) | Fondation Ophtalmologique Adolphe de Rothschild | 2018-12-01 |
| The Swedish BioFINDER 2 Study (NCT03174938) | Skane University Hospital | 2017-05-15 |
| More Than a Movement Disorder: Applying Palliative Care to Parkinson's Disease (NCT03076671) | University of Colorado, Denver | 2017-03-01 |
| Early-onset Alzheimer's Disease Phenotypes: Neuropsychology and Neural Networks (NCT03153371) | University of California, Los Angeles | 2016-04-04 |
| Gait Analysis in Neurological Disease (NCT02994719) | Beth Israel Deaconess Medical Center | 2016-03-01 |
| PROgressive Supranuclear Palsy CorTico-Basal Syndrome Multiple System Atrophy Longitudinal Study UK (NCT02778607) | University College, London | 2014-10-01 |
| Tau Imaging in Subjects With Progressive Supranuclear Palsy, Corticobasal Degeneration and Healthy Volunteers (NCT02167594) | Avid Radiopharmaceuticals | 2014-08-12 |
| Defining Phenotypes of Movement Disorders :Parkinson's Plus Disorders (PD), Essential Tremor (ET), Cortical Basal Degeneration (CBD), Multiple Systems Atrophy (MSA), Magnetoencephalography. (NCT02132052) | University of Colorado, Denver | 2013-11-01 |
| Modifiable Variables in Parkinsonism (MVP) (NCT02194816) | Bastyr University | 2012-09-01 |
| 4 Repeat Tauopathy Neuroimaging Initiative (NCT01804452) | University of California, San Francisco | 2011-01-10 |
| Repetitive Transcranial Magnetic Stimulation (TMS) for Progressive Supranuclear Palsy and Corticobasal Degeneration (NCT01174771) | University of California, Los Angeles | 2008-10-01 |
| A Pilot Trial of Lithium in Subjects With Progressive Supranuclear Palsy or Corticobasal Degeneration (NCT00703677) | Westat | 2008-09-01 |